Although tech giants like Samsung and TSMC currently dominate the silicon landscape, Elon Musk has hinted that Tesla could potentially make its own chips in the future – and while the idea remains a tentative one, it’s certainly not beyond the realms of possibility.
Tesla spends a fortune on silicon. Its Dojo ExaPod supercomputer boasts a staggering 1.1 exaflops of computing power dedicated to training machine learning models for Tesla’s self-driving technology. Musk said in February 2024 that the company will spend “over a billion dollars” on Nvidia and AMD hardware this year just to stay competitive in the AI space. Making its own AI chips would be impossible for Tesla, but it could potentially produce chips for its cars.
Currently, Tesla relies on Samsung for the main chips used in its Autopilot feature. Building a chip factory to create processors specifically for that task would be a significant undertaking. Significant, but not impossible.
“Tesla could do it…”
A recent X exchange between Musk and legendary game developer John Carmack has sparked speculation. Carmack mused about the feasibility of a large tech company creating its own bespoke chips rather than competing with established general-purpose companies. Musk’s response? “Tesla could do it, but I sure hope we don’t have to.”
With growing concerns over the reliance on Korean, Taiwanese and Chinese chipmakers, the possibility of bringing some silicon development in-house is no doubt tempting for Tesla, but the practicalities of such an undertaking mean that without a compelling reason to do so, the company will wisely stick with the status quo for now.
As PC Gamer reports, “Nobody in their right mind would want to spend billions of dollars on something that has the distinct potential of not working right for years, when you can just contract a highly experienced and cost-effective business to do it for you.”
Tesla could do it, but I sure hope we don’t have toMarch 24, 2024
See more
More from TechRadar Pro
Sign up to the TechRadar Pro newsletter to get all the top news, opinion, features and guidance your business needs to succeed!
Here’s something cheery to consider the next time you use an AI tool. Most people involved in artificial intelligence think it could end humanity. That’s the bad news. The good news is that the odds of it happening vary wildly depending on who you listen to.
p(doom) is the “probability of doom” or the chances that AI takes over the planet or does something to destroy us, such as create a biological weapon or start a nuclear war. At the cheeriest end of the p(doom) scale, Yann LeCun, one of the “three godfathers of AI”, who currently works at Meta, places the chances at <0.01%, or less likely than an asteroid wiping us out.
Sadly, no one else is even close to being so optimistic. Geoff Hinton, one of the other three godfathers of AI, says there’s a 10% chance AI will wipe us out in the next 20 years, and Yoshua Bengio, the third of the three godfathers of AI, raises the figure to 20%.
99.999999% chance
At the most pessimistic end of the scale is Roman Yampolskiy, an AI safety scientist and director of the Cyber Security Laboratory at the University of Louisville. He believes it’s pretty much guaranteed to happen. He places the odds of AI wiping out humanity at 99.999999%.
Elon Musk, speaking in a “Great AI Debate” seminar at the four-day Abundance Summit earlier this month, said, “I think there’s some chance that it will end humanity. I probably agree with Geoff Hinton that it’s about 10% or 20% or something like that,” before adding, “I think that the probable positive scenario outweighs the negative scenario.”
In response, Yampolskiy told Business Insider he thought Musk was “a bit too conservative” in his guesstimate and that we should abandon development of the technology now because it would be near impossible to control AI once it becomes more advanced.
“Not sure why he thinks it is a good idea to pursue this technology anyway,” Yamploskiy said. “If he [Musk] is concerned about competitors getting there first, it doesn’t matter as uncontrolled superintelligence is equally bad, no matter who makes it come into existence.”
Sign up to the TechRadar Pro newsletter to get all the top news, opinion, features and guidance your business needs to succeed!
At the Summit, Musk had a solution to avoiding AI wiping out humanity. “Don’t force it to lie, even if the truth is unpleasant,” Musk said. “It’s very important. Don’t make the AI lie.”
If you’re wondering where other AI researchers and forecasters are currently placed on the p(doom) scale, you can check out the list here.
Crystals of ketamine, which is growing in popularity as a treatment for depression and anxiety.Credit: M. I. Walker/Science Photo Library
The drug ketamine is enjoying a second life. First developed as an anaesthetic that was used widely by US battlefield surgeons during the Vietnam war, it is growing in popularity for treating depression and other mental-health conditions. And this week, the drug got its highest-profile endorsement yet.
In an interview with US journalist Don Lemon that was released online Monday, Elon Musk, founder of SpaceX and head of social-media platform X (formerly Twitter), spoke of his own experiences of using the drug to manage what he called a “negative chemical state” similar to depression. Musk said he has a prescription for the drug from “a real doctor” and uses “a small amount once every other week or something like that.” His comments follow the fatal drowning of Friends actor Matthew Perry in October last year, which an investigation blamed on acute effects of the drug.
So what is ketamine, how is it used and is it safe? Nature spoke to three specialists in the field to find out.
How is ketamine used against depression?
It’s complicated. Approved as an anaesthetic by the US Food and Drug Administration in 1970, the drug was delivered intravenously to people undergoing surgery. Ketamine is often still given that way for depression. That demands supervision — typically a person attends a private clinic and is monitored by an anaesthetist as well as the prescribing psychiatrist and support staff.
Wiring up the brain to beat depression
Because it’s long out of patent, there’s little commercial interest in developing new versions of ketamine. Some companies are trying to package it into more convenient oral lozenges, but that’s a challenging formulation.
“The problem with ketamine is if you take it orally, by and large it doesn’t get through to the system because it’s got low bioavailability,” says Allan Young, a consultant psychiatrist at King’s College London who studies mood disorders.
In 2019, the FDA approved a nasal spray that contains a potent ketamine derivative called esketamine as a treatment for severe depression. But it’s more expensive than standard ketamine, so many doctors simply prescribe the tried and tested anaesthetic off-label. They are doing so more often: data suggests that ketamine prescriptions in the United States rose more than fivefold from 2017 to 2022.
Does it work?
Ketamine faces a high bar, as it tends to be given to people with more severe depression who have already tried standard treatments but received little or no benefit. But even in people who did not respond to other drugs, ketamine can prove highly effective.
“We see about 50 to 60% of people having a very clinically meaningful response,” says Joshua Rosenblat, a staff psychiatrist and clinician-researcher at Toronto Western Hospital, Canada. “There’s been over 40 clinical trials now supporting the use of ketamine for depression. For the most part, they’ve just been very, very consistent that there’s a rapid and robust antidepressant effect.”
“We think of ketamine and electroconvulsive therapy (ECT) as quote-unquote big guns that we save for more severe cases,” he adds. (Because of its potency as an anti-depressant, when ketamine first emerged some psychiatrists referred to the drug as “liquid ECT”).
How does it work?
As is true for many psychiatric medicines, scientists aren’t sure how ketamine works at the molecular level in the brain to lift depression. Its benefits seem to come from triggering what psychiatrists call a dissociative state.
How psychedelic drugs achieve their potent health benefits
People who take it “might feel removed from their body, feeling like they’re in a dreamlike state or like they’re floating,” Rosenblat says.
His clinic typically offers those with treatment-resistant depression an acute course of four to six ketamine treatments over two to four weeks. For those patients who respond, the programme switches to a maintenance schedule of a treatment every two to four weeks — which fits with how often Musk said he takes the drug.
“It’s a very important alternative strategy because it works so differently to conventional medicines,” says David Nutt, a neuropsychopharmacologist at Imperial College London.
Is it used beyond depression?
Although esketamine is approved for some forms of depression, ketamine isn’t licensed in the United States as a treatment for psychiatric conditions. But its success against depression is encouraging researchers and even doctors to investigate its effects for other patients.
“When you get an effective treatment in psychiatry, you tend to look out from the initial indication, to look for benefit,” Young says. His team is studying whether it can help with anorexia. Others are looking at the effects on people with alcohol addiction, anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder (PTSD).
“I don’t prescribe for those indications because I don’t think the evidence is sufficient,” Rosenblat says. “But certainly there’s a lot of prescribers who do. I think it’s really grown in popularity for PTSD.”
Is it safe?
Regulations and medical best-practice say that ketamine should only be administered under the proper conditions, which include supervision for several hours afterwards. Some people receiving the drug for depression do react badly, even at relatively low doses.
Taking the tripping out of psychedelic medicine
“It’s very rare for people to have full perceptual disturbances in terms of hallucinations,” Rosenblat says. “It’s more distortion of time and space and colours and sounds.”
Some people he has treated have entered a very unpleasant state that ketamine users call a K-hole. “You feel like you’re dying, like everything goes black,” he says. “It can be distressing. And so we have staff that are trained in grounding people that sit next to them.”
Not everyone who takes ketamine receives that help. Some clinics and doctors administer the drug unsupervised. And then there’s illegal recreational use, which many see as a growing problem because the drug severely affects judgement.
“There are quite a few documented deaths from ketamine,” Nutt says. “Never take it alone or where you can be vulnerable. Not near water, as [Matthew] Perry did, or outside on a cold night admiring the stars.”